Viewing Study NCT02675335


Ignite Creation Date: 2025-12-24 @ 10:23 PM
Ignite Modification Date: 2026-01-05 @ 6:08 PM
Study NCT ID: NCT02675335
Status: WITHDRAWN
Last Update Posted: 2016-09-15
First Post: 2016-02-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Accelerated Wound Healing in Diabetic Ulcers by Sitagliptin
Sponsor: Wolfgang-Michael Franz
Organization:

Study Overview

Official Title: Accelerated Wound Healing in Diabetic Ulcers by Sitagliptin
Status: WITHDRAWN
Status Verified Date: 2016-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: SitaDFU
Brief Summary: The purpose of the study is to test the effect of Sitagliptin on the healing of stable, nonhealing diabetic foot ulcers. This is a randomized placebo-controlled Trial.
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
2015-005226-19 EUDRACT_NUMBER None View
MISP 52815 OTHER Merck Investigator Studies Program View